Topics
High-grade gliomas | Diagnosis | Progression/Pseudoprogression
Home > Publications > Topics > High-grade gliomas > Diagnosis > Progression/Pseudoprogression
Satragno C, Schiavetti I, Cella E, Picichè F, Falcitano L,
Resaz M, Truffelli M, Caneva S, Mattioli P, Esposito D, Ginulla A,
Scaffidi C, Fiaschi P, D'Andrea A, Bianconi A, Zona G, Barletta L,
Roccatagliata L, Castellan L, Morbelli S, Bauckneht M, Donegani I,
Nozza P, Arnaldi D, Vidano G, Gianelli F, Barra S, Bennicelli E,
Belgioia L; disease management team on Neuroncology of IRCCS
Ospedale Policlinico San Martino.
Systemic
inflammatory markers and volume of enhancing tissue on
post-contrast T1w MRI images in differentiating true tumor
progression from pseudoprogression in high-grade glioma.
Clin
Transl Radiat
Oncol. 2024 Aug 30;49:100849. doi:
10.1016/j.ctro.2024.100849. PMID:
39318678. Observational study. ˍ
*Puranik AD, Dev ID, Rangarajan V, Jain Y, Patra S, Purandare NC,
Sahu A, Choudhary A, Bhattacharya K, Gupta T, Chatterjee A,
Dasgupta A, Moiyadi A, Shetty P, Singh V, Sridhar E, Sahay A, Shah
A, Menon N, Ghosh S, Choudhury S, Shah S, Agrawal A,
Lakshminarayanan N, Kumar A, Gopalakrishna A.
FET
PET to differentiate
between post-treatment changes and recurrence in high-grade
gliomas: a single center
multidisciplinary clinic controlled study.
Neuroradiology.
2024 Nov 11. doi:
10.1007/s00234-024-03495-9. PMID:
39527264. Observational study. ˍ